Cervical Cancer Current Events

Cervical Cancer Current Events, Cervical Cancer News Articles.
Sort By: Most Viewed | Most Recent
Page 1 of 25 | 1000 Results
Regular smear tests boost chances of cure from 66 percent to 92 percent
Women can boost their chances of surviving cervical cancer substantially through regular cervical screening, claims a research paper published today on bmj.com. (2012-03-01)

How have HPV vaccines affected cervical cancer screening?
A new review looks at cervical cancer screening in the era of HPV vaccination. The review notes that trials have demonstrated the efficacy and safety of vaccines against HPV infection, but the complete effect of HPV vaccination as a cancer prevention strategy may not be fully evident for decades, given the slow progression from HPV infection to the development of cervical cancer. (2017-06-07)

HPV test detects more pre-cancerous cells than conventional smear test
Human papillomavirus screening detects more cervical severe pre-cancerous lesions than conventional cervical screening, finds a study published on bmj.com today. (2010-04-27)

Possible link between oral contraceptive use and risk of cervical cancer
Authors of a systematic review in this week's issue of The Lancet confirm previous findings highlighting a potential link between extended use of oral contraceptives and an increased risk of cervical cancer. However the authors stress that more research is needed to establish the extent to which women remain at an increased risk of cervical cancer after they have stopped using this form of contraception. (2003-04-03)

Enabling women to use home test kits could increase HPV detection
More high risk cases of human papilloma virus could be detected by offering home testing kits to women who do not come forward for cervical screening, according to research published on bmj.com today. (2010-03-11)

Cervical cancer burden can be solved with current technology and modest resources
Much of the world's cervical cancer problem can be solved with existing or soon-to-be-available technology, sufficient will and modest resources, say authors of a seminar in this week's edition of the Lancet. (2007-09-06)

Women still at risk of cervical cancer despite treatment removing pre-cancerous cells
Women who have had pre-cancerous cells removed remain at higher than average risk of developing cervical cancer in the 20 years following treatment, says research in this week's BMJ. (2005-11-17)

Genetic link to cervical cancer
Certain combinations of genes that encode receptors on innate immune cells increase the risk of developing cervical cancer, according to a study by Mary Carrington and colleagues in the April 4 issue of The Journal of Experimental Medicine. (2005-04-04)

Women with AIDS face cervical cancer threat
The largest screening program for cervical cancer in the developing world shows that women living with AIDS face a high risk of developing cervical cancer and must be screened. (2007-11-30)

Urine testing might prove to be an alternative screening test for cervical cancer
A study involving 143 women from Senegal, West Africa has shown that a simple urine test might provide an alternative to Pap screening for cervical cancer. In most of the world, cervical cancer is the second leading cause of cancer-related death among women. The routine way to screen for cervical cancer is through Pap screening and pelvic exams. (2004-10-18)

What's the best test for cervical cancer? Pap, HPV or both?
Should US women be screened for cervical cancer with Pap tests, HPV tests or both? According to researchers from Boston University School of Medicine and Boston Medical Center while the merits of screening tests and screening intervals warrant further discussion, they firmly believe that increasing the number of women who participate in cancer screenings and ensuring that women are not lost to follow-up with lengthened screening intervals is more important than the choice of test to decrease rates of cervical cancer. (2014-06-09)

Cervical cancer could be eliminated within a century
Cervical cancer could be eliminated worldwide as a public health issue within the next century. This is the conclusion of two studies published today in The Lancet by an international consortium of researchers codirected by Professor Marc Brisson from Université Laval's Faculty of Medicine and the CHU de Québec-Université Laval Research Centre. The researchers are even more optimistic about North America, stating that the disease could be almost completely eliminated by 2040. (2020-01-30)

Frazer welcomes Federal Government decision on Gardasil
The Director of The University of Queensland's Centre for Immunology and Cancer Research, Professor Ian Frazer, has welcomed a Federal Government decision to place cervical cancer vaccine Gardasil on the National Immunisation Program. (2006-12-06)

Further Evidence On The Effect Of The UK Cervical Screening Programme
Dr. Peter Sasieni and Joanna Adams from the Imperial Cancer Research Fund support recent findings of a beneficial effect of the UK's national cervical screening programme. They say that before the relaunch of the programme in 1988 screening had a minimal effect on mortality, but since its relaunch screening appears to have reduced cervical cancer mortality by over 60 per cent in those aged under 55 years. (1999-05-07)

New cervical smear tests perform no better than conventional tests
New cervical smear tests are unreliable and should not replace conventional tests (PAP smears) according to a study in this week's BMJ. (2003-04-03)

New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer. (2005-11-17)

Disasters can affect cervical cancer screening for years
Screening is important for the early detection of cervical cancer, but rates were significantly affected, in some areas for years, following a devastating earthquake and tsunami in Japan. (2020-03-27)

HPV vaccine reduced cervical abnormalities in young women
Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in Canadian Medical Association Journal. (2016-07-04)

Grant launches cervical cancer-free Indiana initiative
Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation. Cervical Cancer-Free America is an initiative designed to raise awareness, increase screenings for cervical cancer and increase rates of human papillomavirus vaccination with the ultimate goal of eliminating cervical cancer. (2010-12-02)

Researchers probe HPV's manipulation of immune system
Researchers from New Zealand's University of Otago have gained fresh insights into how one of the main viruses that cause cervical cancer evades its hosts' immune systems. Their findings, which are published in the international journal Scientific Reports, suggest that a protein known as E7, produced by a high-risk type of human papillomavirus (HPV16), may be the key player in suppressing the body's immune response to the virus. (2016-10-06)

Zoledronic acid zings cervical cancer
Cervical cancer is the second most common cancer among women worldwide. In the September 1 issue of the Journal of Clinical Investigation, researchers from the University of California, San Francisco, found that a drug called zoledronic acid, which is currently used in the treatment of patients with bone metastases, was able to slow cervical cancer progression and growth in a mouse model. These data indicate this approved drug may be useful for cervical cancer treatment. (2004-09-01)

Targeted drug may prolong survival of patients with cervical cancer
A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease. (2014-03-10)

Study finds decreased rates of high-grade cervical lesions in young women
A new analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations. (2015-06-22)

HPV strains may impact cervical cancer prognosis
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumours caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis. (2020-08-10)

Cervical screening is working well, but is labour intensive
The NHS cervical screening programme is working well and preventing deaths, but is labour and resource intensive - around 1,000 women need to be screened for 35 years to prevent one death, say researchers in this week's BMJ. (2003-04-24)

Current guidelines underestimate US cervical cancer incidence and older women's risk
Rates of cervical cancer in American women may be higher than previously thought, and the disease may arise most often at an age when adequately screened women are advised to stop getting screened. The findings come from a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The results should be taken into consideration when the national guidelines for cervical cancer screening are reviewed. (2014-05-12)

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness. The analysis, published by the Journal of the Royal Society of Medicine, assessed 12 published Phase 2 and 3 randomized controlled efficacy trials of the HPV vaccines Cervarix and Gardasil. (2020-01-21)

A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV
A study in Mozambique reveals that a majority of adolescent girls interviewed would be willing to get vaccinated against Human Papilloma Virus (HPV) if the vaccine was available in the country. These results are encouraging with regard to vaccine introduction and reducing mortality associated with cervical cancer in Mozambique. The investigation was led by the Manhiça Health Research Center (CISM) and ISGlobal, an institution supported by (2018-06-04)

IUD reduces the risk of cervical cancer
Intrauterine devices (IUDs) may protect against cervical cancer. This is the conclusion of the broadest epidemiological study to date in which has participated the research group in Viruses and Cancer of IDIBELL, published at the Lancet Oncology. (2011-09-13)

Promising cervical cancer study
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site research project by Bradley J. Monk, M.D., is expected to change the standard of care in advanced cervical cancer. (2014-02-21)

Cervical cancer and pre-cancer cervical growths require single HPV protein
Human papillomavirus (HPV) has long been implicated in cervical cancer, but details of how it happens have remained a mystery. Now researchers at the University of Wisconsin-Madison have found that a single HPV protein is required for cervical cancer and even pre-cancer growths in the cervix to survive. (2012-09-14)

Screening for HPV persistence and cervical cancer risk
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute. (2011-09-06)

HPV vaccination is associated with reduced risk of cervical lesions in Denmark
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published Feb. 19 in the Journal of the National Cancer Institute. (2014-02-19)

Self-sampling identifies twice as many women at risk of cervical cancer
Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment. This is shown by researchers at Uppsala University in the first randomised study in the world comparing two ways of identifying cervical cancer, published today in the British Journal of Cancer. (2018-02-15)

Cervical Cancer Screening In Women With Learning Disability Is Lower Than General Population
Coverage in the cervical screening programme is markedly lower for women with learning disability than for the general female population, says a study in this week's BMJ. A survey found that of those eligible for a smear test, only 13 per cent of women with learning disability had received one in the last five years, as opposed to 88 per cent of women in the general population. (1999-03-05)

HPV linked to cervical lesions
Infection with humanpapillomavirus (HPV) is linked to an increased likelihood of cervical lesions in women, finds a study in this week's BMJ. The study, which involved over 10,000 women, found that those who were HPV positive had a significantly increased risk of developing low and high grade cervical lesions compared to women who did not have the virus. (2002-09-12)

Should cervical screening stop at age 50?
It is not consistent to stop screening women after age 50 because the risk of cervical cancer -- even after several negative smear results -- is similar to that at younger ages, concludes a study published on bmj.com today. (2009-04-23)

Transient increase in cervical cancer risk in oral contraceptive users
Current users of oral contraceptives are at increased risk of developing cervical cancer, however 10 years after stopping use the risk returns to that seen for never-users. These are the conclusions of authors of an article published in this week's edition of The Lancet. (2007-11-08)

Cervical cancer: DNA-based test more accurate than repeat smear ('Pap')
In women who have a potentially or mildly abnormal cervical smear, using a DNA-based test can identify those at higher risk of having precursors of cervical cancer, according to a new Cochrane systematic review. The authors found that the DNA-based test identified patients in possible need of treatment more accurately than a repeat smear test. (2013-03-27)

New Insight into cervical cancer development: turning it up a notch
A collaboration of scientists from Harvard Medical School and Brigham and Women's Hospital have uncovered a key genetic event in the progression of malignant cervical cancer -- and a potential new therapeutic target. The report is published in Genes & Development. (2002-08-31)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.